The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

Stifel analyst Jonathan Block resumed coverage of DexCom (DXCM) with a Buy rating and $85 price target The firm’s due diligence was “upbeat” for ...

Walmart will become the first U.S. retailer to sell an over-the-counter continuous glucose monitor in physical stores, as ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...

The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, ...

A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California.

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...

San Diego-based Dexcom Inc., is the target of a class action lawsuit in U.S. district court over the company’s G7 continuous glucose monitors, an action which follows a U.S. FDA warning letter by a ...

Dekoda monitors pee, bowel movements, and blood in the toilet bowl.  The device retails for $599 and launched on Wednesday.  You probably aren't drinking enough water, and Kohler's newest device tells ...

More than 38 million Americans have diabetes and regular blood sugar monitoring is crucial. A team of researchers is working ...